Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04614766
Title A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors (SPORE-3)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors David Bushnell
Indications

neuroendocrine tumor

paraganglioma

pheochromocytoma

Therapies

131I-MIBG + lutetium Lu 177 dotatate

lutetium Lu 177 dotatate

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.